DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
Wang C, Zainal NS, Chai SJ, Dickie J, Gan CP, Zulaziz N, Lye BKW, Sutavani RV, Ottensmeier CH, King EV, Abraham MT, Ismail SMB, Lau SH, Kallarakkal TG, Mun KS, Zain RB, Abdul Rahman ZA, Thomas GJ, Cheong SC, Savelyeva N, Lim KP.
Wang C, et al. Among authors: gan cp.
Front Immunol. 2021 Oct 18;12:763086. doi: 10.3389/fimmu.2021.763086. eCollection 2021.
Front Immunol. 2021.
PMID: 34733290
Free PMC article.